Entia Biosciences competitorsClear all

Entia Biosciences's top competitors include Touchlight Genetics, Personal Genome Diagnostics (PGD), Eloxx Pharmaceuticals and Osiris Therapeutics.
Entia Biosciences
Entia Biosciences
Entia Biosciences offers nutrigenomics identifying and validating solutions for the organic health, beauty, and agricultural markets.
Touchlight Genetics
Touchlight Genetics
Touchlight Genetics Ltd is a biotechnology company operating in the field of DNA therapies and DNA technology.
Personal Genome Diagnostics (PGD)
Personal Genome Diagnostics (PGD)
Personal Genome Diagnostics Inc. develops patient-specific analysis of the cancer genome by using advanced tools and technologies.
Eloxx Pharmaceuticals
Eloxx Pharmaceuticals
Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for rare and ultra-rare genetic diseases.
Osiris Therapeutics
Osiris Therapeutics
Osiris Therapeutics researches, develops, manufactures, markets, and distributes regenerative medicine products in the United States.
Founding Date
Founding Date
N/A
Founding Date
2008
Founding Date
2010
Founding Date
2013
Founding Date
1992
Type
Type
Public
Type
Private
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
Sherwood, US HQ
Locations
London, GB HQ
Locations
Baltimore, US HQ
Locations
Waltham, US HQ
Rehovot, IL
Locations
Columbia, US HQ
Employees
Employees
12
Employees
333% increase
Employees
230
Employees
2993% increase
Employees
3421% increase
Valuation ($)
Valuation ($)
279 k
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
351.2 m
Valuation ($)
655.7 m
Alexa Website Rank
Alexa Website Rank
311342
Alexa Website Rank
566835
Alexa Website Rank
632924
Alexa Website Rank
N/A
Alexa Website Rank
527479

Financial

Revenue (est.)
Revenue (est.)
$265.5k (FY, 2016)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$142.8m (FY, 2018)
Cost of goods
Cost of goods
$91.5k (FY, 2016)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$38.1m (FY, 2018)
Gross profit
Gross profit
$174k (FY, 2016)
Gross profit
N/A
Gross profit
N/A
Gross profit
N/A
Gross profit
$104.7m (FY, 2018)
Net income
Net income
($1.4m) (FY, 2016)
Net income
N/A
Net income
N/A
Net income
($47.2m) (FY, 2018)
Net income
$36.9m (FY, 2018)

Funding

Total funding raised
Total funding raised
$ 1.5m
Total funding raised
N/A
Total funding raised
$ 141.3m
Total funding raised
$ 30m
Total funding raised
$ 65m
For sources of this data, please see the company profile

View company profiles

Touchlight Genetics
HQ
London, GB
Employees
33↑ 3% increase

Touchlight Genetics Ltd is a biotechnology company operating in the field of DNA therapies and DNA technology.

View company
Personal Genome Diagnostics (PGD)
HQ
Baltimore, US
Employees
230

Personal Genome Diagnostics Inc. develops patient-specific analysis of the cancer genome by using advanced tools and technologies.

View company
Eloxx Pharmaceuticals
HQ
Waltham, US
Employees
29

Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for rare and ultra-rare genetic diseases.

View company
Osiris Therapeutics
HQ
Columbia, US
Employees
342↑ 1% increase

Osiris Therapeutics researches, develops, manufactures, markets, and distributes regenerative medicine products in the United States.

View company